Forskolin, an inducer of cAMP, up-regulates acetylcholinesterase expression and protects against organophosphate exposure in neuro 2A cells
- First Online:
- 172 Downloads
Bioscavenger prophylactic therapy using purified human acetylcholinesterase (AChE) or butylcholinesterase (BChE) is a promising treatment for future protection against chemical warfare nerve agent exposure. Potential immune response due to the complex structure of cholinesterases, mutations, post-translational modifications, and genetic variation is a limiting factor against purified enzyme therapy. We investigated an alternative bioscavenger approach using Forskolin, an inducer of intracellular cyclic AMP (cAMP), which activates AChE promoter and up-regulates its expression. A mouse neuronal cell line, Neuro 2A, was treated with various doses of Forskolin and analysis of the expressed enzyme indicates that the AChE activity was significantly increased in cells exposed to repeated administration of the drug every other day for 7–10 days. Cholinesterase enzyme assays showed that the enzyme activity was increased approximately 2-fold for the extracellular enzyme and 3-fold for the intracellular enzyme. The optimal dose found for extracellular enzyme production was 12–24 μM Forskolin, while the optimal dose for intracellular was 12 μM. In parallel with the rise in the AChE level, the morphology of Forskolin-treated cells showed neurite growth with increasing doses. Forskolin treatment protects Neuro 2A cells from Diisopropylflurophophate (DFP), a surrogate of the organophosphate chemical warfare agents soman and sarin, induced toxicity in Neuro 2A cells. These results indicate that transcriptional inducers, such as Forskolin, can sufficiently up-regulate cellular AChE production and protect cells against organophosphate toxicity.
Keywordsacetylcholinesterase organophosphates transcriptional regulators neuronal cell lines gene expression neuroprotection
Unable to display preview. Download preview PDF.
- 4.Holstege CP, Kirk M, Sidell FR: Chemical warfare. Nerve agent poisoning. Crit Care Clin 13: 923–942, 1997Google Scholar
- 15.Kitazawa M, Yamakuni T, Song SY, Kato C, Tsuchiya R, Ishida M, Suzuki N, Adachi E, Iwashita S, Ueno S, Yanagihara N, Taoka M, Isobe T, Ohizumi Y: Intracellular cAMP controls a physical association of V-1 with CapZ in cultured mammalian endocrine cells. Biochem Biophys Res Commun 331: 181–186, 2005PubMedCrossRefGoogle Scholar
- 16.Newton RA, Smit SE, Barnes CC, Pedley J, Parsons PG, Sturm RA: Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides, 2005Google Scholar
- 24.Inokoshi J, Katagiri M, Arima S, Tanaka H, Hayashi M, Kim YB, Furumai R, Yoshida M, Horinouchi S, Omura S: Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I. Biochem Biophys Res Commun 256: 372–376, 1999PubMedCrossRefGoogle Scholar